Test Code 0610U

Test Name Benzphetamine as Metabolites, Urine

Purpose
Therapeutic Drug Monitoring; Abuse Monitoring
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80324
New York State Approval Status

Approved

Turnaround Time

7 days

Test Includes
1 Amphetamine Benzphetamine Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 50 Anorexigenic, Stimulant
2 Methamphetamine Benzphetamine Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 50 Stimulant

test
Compliance Statement
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
190631
Specimen Type
Urine
Requested Volume
1 mL
Minimum Volume
0.2 mL
Special Handling
None
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
None

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 7 day(s)
Refrigerated: 6 month(s)
Frozen (-20 °C): 6 month(s)
1 Amphetamine Benzphetamine Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 50 Anorexigenic, Stimulant
2 Methamphetamine Benzphetamine Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 50 Stimulant

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.